Senate Resolution 394 Printer's Number 2027
PENNSYLVANIA, October 8 - WHEREAS, EB simplex is the most common form of EB, while the
other forms are relatively less common and affect the patient
more severely; and
WHEREAS, The presence and type of EB is differentiated by the
gene that is affected and the particular protein that is
produced by that gene, therefore, EB can be the result of a
mutation in genes that produce 1 of 18 different structural
proteins; and
WHEREAS, It has been estimated that 1 out of every 20,000
births, approximately 200 children a year, is affected with some
type of EB, and the disorder occurs in every group throughout
the world, affecting both sexes equally; and
WHEREAS, With skin as fragile as a butterfly wing, EB
patients are dubbed "Butterfly Children"; and
WHEREAS, The awareness week for EB is commonly referred to as
"Butterfly Children Awareness Week"; and
WHEREAS, On the outside, physical wounds prevent them from
normal daily activities enjoyed by other children as the
slightest friction produces agonizing wounds that can cover up
to 75% of their bodies; and
WHEREAS, Unfortunately, there is a lack of long-term research
surrounding EB, and most physicians, nationally and
internationally, are unaware of the disorder and its
complexities, which results in less than optimal treatment
options for even the most common secondary complications; and
WHEREAS, Researchers from around the globe are investigating
new therapies to treat and cure EB, thereby leading to a better
quality of life; and
WHEREAS, It is imperative that there is greater public
awareness of this serious health issue, and more must be done to
20260SR0394PN2027 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.